The Inactivated Vaccines Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Inactivated Vaccines Market?
The market size of inactivated vaccines has seen consistent growth over the past few years. It is projected to increase from $6.19 billion in 2024 to $6.44 billion in 2025, with a compound annual growth rate (CAGR) of 4.0%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Inactivated Vaccines Industry?
The Inactivated Vaccines Global Market Report 2025 anticipates that by 2029, the market for inactivated vaccines will reach a value of $7.75 billion. The market is also expected to experience a compound annual growth rat
Download Your Free Sample of the 2025 Inactivated Vaccines Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Inactivated Vaccines Market?
The key drivers in the inactivated vaccines market are:
• Surge in pandemic preparedness efforts
• Expansion of vaccine coverage globally
• Advancements in biomanufacturing processes
• Initiatives aimed at promoting health equity
Global Market Segmentation: Identifying Major Inactivated Vaccines Industry Segments
The inactivated vaccines market covered in this report is segmented –
1) By Type: Viral Vaccine, Bacterial Vaccine
2) By Method Of Inactivation: Solvent Detergent, Radiation, pH Concentration, Heat Inactivation, Other Methods Of Inactivation
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels
Pre-order the 2025 Inactivated Vaccines Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Inactivated Vaccines Market?
The key trends in the inactivated vaccines market are:
• The rise of mRNA vaccine platforms is a major upcoming trend.
• The use of combination vaccines is steadily becoming more popular.
• There is a growing trend towards the development of thermostable vaccines.
• The proliferation of digital vaccine passports is shaping the future of the market.
Who Are the Top Competitors & Leading Players in the Inactivated Vaccines Market?
Major companies in the inactivated vaccines market are:
• Pfizer Inc.
• Johnson & Johnson Services Inc.
• Sinopharm Group Co. Ltd.
• Merck & Co. Inc.
• Sanofi S.A.
• GlaxoSmithKline PLC
• Takeda Pharmaceutical Company Limited
• Astellas Pharma Inc.
• CSL Limited
• Daiichi Sankyo Company Limited
• Mitsubishi Tanabe Pharma Corporation
• Novavax Inc.
• Zydus Lifesciences Ltd.
• Sinovac Biotech Ltd.
• Biological E Limited
• Hualan Biological Engineering Inc.
• CanSino Biologics Inc.
• Shenzhen Kangtai Biological Products Co. Ltd.
• Serum Institute of India Pvt. Ltd.
• Beijing Tiatan Biological Products Co. Ltd.
• Valneva SE
• Bavarian Nordic A/S
• Beijing Minhai Biotechnology Co. Ltd.
• Bharat Biotech International Limited
• Panacea Biotec Ltd.
• Sinergium Biotech SA
• Bharat Immunologicals and Biologicals Corporation Limited
• Haffkine Biopharmaceutical Corporation Limited
• Incepta Vaccine Ltd.
• Changchun BCHT Biotechnology Co. Ltd.
Regional Dominance: Which Area Leads the Global Inactivated Vaccines Market?
North America was the largest region in the inactivated vaccines market in 2024
